MedPath

Subjective Sleep and Fatigue During and After Acute Diverticulitis

Completed
Conditions
Acute Diverticulitis
Registration Number
NCT01840904
Lead Sponsor
Herlev Hospital
Brief Summary

The purpose of this study is to investigate subjective sleep quality and fatigue during and after Acute uncomplicated diverticulitis assessed by questionnaires and a sleep-diary. The investigators hypothesis is that subjective sleep and fatigue are correlated with the inflammatory activities.

Detailed Description

An increasing number of experimental studies have showed that inflammation can induce disturbances in sleep architecture, mediated by cytokines. some studies showed that cytokines also induce daytime fatigue. In this study the investigators aim to describe the patient experiences of sleep and fatigue during the acute inflammation and the recovery, and the investigators seek to exam the correlation of fatigue with Polysomnography-measured night sleep and cytokine levels in plasma.

Following methods will be applied

* Other: Karolinska Sleepiness Scale

* Other: Physical Fatigue Scale

* Other: Visual Analog Scale and 10 point-scales to measure fatigue, general well-being, subjective sleep and pain

* Other: Sleep-diary

* Device: Polysomnograph - Embla Titanium (Natus Medical Incorporated, USA)

* Procedure: Plasma cytokines (IL-2, IL-6 and TNF-alfa(tumor necrosis factor))

* Procedure: Plasma CRP(C reactive protein) and leukocytes

* Device: Wrist-Actigraph - Octagonal Basic Motionlogger, Ambulatory monitoring Inc, New York, USA

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
13
Inclusion Criteria
  • CT-verified diverticulitis patients managed by antibiotic treatment at Herlev Hospital
  • Pain and fever occurred less than 72 hours prior to the admission
  • ASA (American Society of Anesthesiologists) score I to III
Exclusion Criteria
  • Surgical intervention needed
  • Complicated diverticulitis
  • Complications in relation to diverticulitis
  • Pain and fever occurred more than 72 hours prior to the admission
  • In anticoagulant treatment and heart rate control treatment
  • Known Autoimmune disease
  • Known medically treated sleep-disorder (insomnia, restless legs etc.) and sleep apnea
  • Shift-work or jetlag
  • Daily use of opioid, psychopharmaca, opioids or anxiolytics (including Hypnotics)
  • Known psychiatry conditions in treatment with psychopharmaca
  • Daily alcohol intake of more than 5 units or drug abuse
  • Missing written consent
  • Diabetes Mellitus
  • Predicted bad compliance
  • Pregnant or breast-feeding
  • Urine or fecal incontinence
  • Severe kidney disease
  • Current cancer

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in pain during acute uncomplicated diverticulitis from baseline score at remission (14th, 21st and 30th day)1st-10th day and 14th, 21st, 30th day following the admission

Pain measured on VAS

Changes in Sleep quality during acute uncomplicated diverticulitis from baseline score at remission (14th, 21st and 30th day)1st-10th day and 14th, 21st, 30th day following the admission

1. subjective sleep quality measured by a Visual Analog Scale (VAS) at given time frame

2. sleep-diary recording sleep quantity of day and night sleep at given time frame

Changes in Sleepiness during acute uncomplicated diverticulitis from baseline score at remission (14th, 21st and 30th day)1st-10th day and 14th, 21st, 30th day following the admission

Sleepiness measured by Karolinska Sleepiness Scale at given time frame

Changes in fatigue during acute uncomplicated diverticulitis from baseline score at remission (14th, 21st and 30th day)1st-10th day and 14th, 21st, 30th day following the admission

1. General fatigue measured on Visual Analog Scale at given time frame

2. Physical fatigue measured on a 10 points scale at given time frame

Changes in general well-being during acute uncomplicated diverticulitis from baseline score at remission (14th, 21st and 30th day)1st-10th day and 14th, 21st, 30th day following the admission

general well being measured on VAS

Secondary Outcome Measures
NameTimeMethod
accuracy of sleep diary compared to Polysomnography (PSG) in measuring sleep data1st-2nd day and 30th day following the admission

Sleep quantity registered by the sleep diary compared with PSG measured sleep quantity at given time frame

accuracy of sleep diary compared to actigraph in measuring sleep data1st-10th day and 14th, 21st, 30th day following the admission

Sleep quantity registered by the sleep diary compared with actigraph measured sleep quantity at given time frame

correlation between sleepiness and level of cytokines in patient's plasma1st and 2nd and 30th day following the admission

Investigator seek to find correlations between levels of IL-2, IL-6, TNF-alpha, CRP, Leucocytes and subjective sleepiness measured by Karolinsk Sleepiness Scale

correlation between pain and level of cytokines in patient's plasma1st and 2nd and 30th day following the admission

Investigator seek to find correlations between levels of IL-2, IL-6, TNF-alpha, CRP, Leucocytes and subjective pain measured by VAS.

correlation between fatigue and level of cytokines in patient's plasma1st and 2nd and 30th day following the admission

Investigator seek to find correlations between levels of IL-2, IL-6, TNF-alpha, CRP, Leucocytes and subjective fatigue measured by VAS and a 10 points scale.

correlation between general well-being and level of cytokines in patient's plasma1st and 2nd and 30th day following the admission

Investigator seek to find correlations between levels of IL-2, IL-6, TNF-alpha, CRP, Leucocytes and general well-being measured by VAS

Trial Locations

Locations (1)

Department D, Herlev Hospital

🇩🇰

Herlev, Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath